Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease

Brain Research Reviews

Volumn 32, Issue 1, 2000, Pages 192-202

  Ressot, Catherine ^a   Bruzzone, Roberto ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Channel; Charcot Marie Tooth; Gap junction; Mutation; Myelin; Neuropathy; PNS; Schwann cell; Xenopus oocyte

Indexed keywords

CONNEXIN 32; GAP JUNCTION PROTEIN; ION CHANNEL;

CHANNEL GATING; GAP JUNCTION; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; IMMUNOCYTOCHEMISTRY; ION TRANSPORT; MYELIN SHEATH; NEUROPATHY; OOCYTE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SCHWANN CELL; SECOND MESSENGER; SHORT SURVEY; X CHROMOSOME LINKAGE; XENOPUS LAEVIS;

EID: 0034070195     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00081-8     Document Type: Article

References (94)

1. Bruzzone R., White T.W., Paul D.L. Connections with connexins: the molecular basis of direct intercellular signaling. Eur. J. Biochem. 238:1996;1-27.
2. Nicholson S.M., Bruzzone R. Gap junctions: getting the message through. Curr. Biol. 7:1997;R340-R344.
3. White T.W., Paul D.L. Genetic diseases and gene knockouts reveal diverse connexin functions. Annu. Rev. Physiol. 61:1999;283-310.
4. Willecke K., Kirchhoff S., Plum A., Temme A., Thönnissen E., Ott T. Biological functions of connexin genes revealed by human genetic defects, dominant negative approaches and targeted deletions in the mouse. Novartis Found. Symp. 219:1999;76-88. discussion 88-96.
5. Bergoffen J., Scherer S.S., Wang S., Oronzi Scott M., Bone L.J., Paul D.L., Chen K., Lensch M.W., Chance P.F., Fischbeck K.H. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science. 262:1993;2039-2042.
6. Scherer S.S., Deschênes S.M., Xu Y.-T., Grinspan J.G., Fischbeck K.H., Paul D.L. Connexin32 is a myelin-related protein in the PNS and CNS. J. Neurosci. 15:1995;8281-8294.
7. Chandross K.J., Kessler J.A., Cohen R.I., Simburger E., Spray D.C., Bieri P., Dermietzel R. Altered connexin expression after peripheral nerve injury. Mol. Cell. Neurosci. 7:1996;501-518.
8. Nelis E., Haites N., Van Broeckhoven C. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies. Hum. Mutat. 13:1999;11-28.
9. S.M. Nicholson, C. Ressot, D. Gomès, P. D'Andrea, J. Perea, N. Duval, R. Bruzzone, Connexin32 in the peripheral nervous system: functional analysis of mutations associated with X-linked Charcot-Marie-Tooth syndrome and implications for the pathophysiology of the disease, Ann. N. Y. Acad. Sci. (1999) in press.
10. Scherer S.S., Bone L.J., Deschênes S.M., Abel A., Balice-Gordon R.J., Fischbeck K.H. The role of the gap junction protein connexin32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease. Novartis Found. Symp. 219:1999;175-185. discussion 185-187.
11. T.A. Bargiello et al., Characterization of functional CMTX mutations: implications for the disease, Brain Res. Rev. (1999) this issue.
12. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin. Genet. 6:1974;98-118.
13. Harding A.E. From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins. Brain. 118:1995;809-818.
14. Suter U., Snipes G.J. Biology and genetics of hereditary motor and sensory neuropathies. Annu. Rev. Neurosci. 18:1995;45-75.
15. Harding A.E., Thomas P.K. The clinical features of hereditary motor and sensory neuropathies types I and II. Brain. 103:1980;259-280.
16. Lupski J.R. Charcot-Marie-Tooth disease: lessons in genetic mechanisms. Mol. Med. 4:1998;3-11.
17. Lemke G. Unwrapping the genes of myelin. Neuron. 1:1988;535-543.
18. Warner L.E., Mancias P., Butler I.J., McDonald C.M., Keppen L., Koob K.G., Lupski J.R. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat. Genet. 18:1998;382-384.
19. Topilko P., Schneider-Maunoury S., Levi G., Baron-Van Evercooren A., Chennoufi A.B., Seitanidou T., Babinet C., Charnay P. Krox-20 controls myelination in the peripheral nervous system. Nature. 371:1994;796-799.
20. Gal, Mücke J., Theile H., Wieacker P.F., Ropers H.-H., Wienker T.F. X-linked dominant Charcot-Marie-Tooth disease: suggestion of linkage with a cloned DNA sequence from the proximal Xq. Hum. Genet. 70:1985;38-42.
21. Fischbeck K.H., Ar-Rushdi N., Pericak-Vance M., Rozear M.P., Roses A.D., Fryns J.P. X-linked neuropathy: gene localization with DNA probes. Ann. Neurol. 20:1986;527-532.
22. Rozear M.P., Pericak-Vance M.A., Fischbeck K., Stajich J.M., Gaskell P.C. Jr., Krendell D.A., Graham D.G., Dawson D.V., Roses A.D. Hereditary motor and sensory neuropathy. X-linked: a half century follow-up. Neurology. 37:1987;1460-1465.
23. Hahn A.F., Brown W.F., Koopman W.J., Feasby T.E. X-linked dominant hereditary motor and sensory neuropathy. Brain. 113:1990;1511-1525.
24. Ionasescu V.V., Trofatter J., Haines J.L., Ionasescu R., Searby C. Mapping of the gene for X-linked dominant Charcot-Marie-Tooth neuropathy. Neurology. 42:1992;903-908.
25. Nicholson G., Nash J. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology. 43:1993;2558-2564.
26. Birouk N., LeGuern E., Maisonobe T., Rouger H., Gouider R., Tardieu S., Gugenheim M., Routon M.C., Leger J.M., Agid Y., Brice A., Bouche P. X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study. Neurology. 50:1998;1074-1082.
27. S.S. Scherer, J.L. Salzer, Axon-Schwann cell interactions during peripheral nerve degeneration and regeneration, in: K.R. Jessen, W.D. Richardson (Eds.), Glial Cell Development, BIOS Scientific Publishers, Oxford, UK, 1996, pp. 165-196.
28. Ainsworth P.J., Bolton C.F., Murphy B.C., Stuart J.A., Hahn A.F. Genotype/phenotype correlation in affected individuals of a family with a deletion of the entire coding sequence of the connexin 32 gene. Hum. Genet. 103:1998;242-244.
29. Ionasescu V.V., Searby C., Ionasescu R., Neuhaus I.M., Werner R. Mutations of the noncoding region of the connexin32 gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Neurology. 47:1996;541-544.
30. Neuhaus I.M., Dahl G., Werner R. Use of alternate promoters for tissue-specific expression of the gene coding for connexin32. Gene. 158:1995;257-262.
31. Söhl G., Gillen G., Bosse F., Gleichmann M., Müller H.W., Willecke K. A second alternative transcript of the gap junction gene connexin32 is expressed in murine Schwann cells and modulated in injured sciatic nerve. Eur. J. Cell Biol. 69:1996;267-275.
32. Paul D.L. Molecular cloning of cDNA for rat liver gap junction protein. J. Cell Biol. 103:1986;123-134.
33. Kumar N.M., Gilula N.B. Cloning and characterization of human and rat liver cDNAs coding for a gap junction protein. J. Cell Biol. 103:1986;767-776.
34. Heynkes R., Kozjek G., Traub O., Willecke K. Identification of a rat liver cDNA and mRNA coding for the 28 kDa gap junction protein. FEBS Lett. 205:1986;56-60.
35. Sandri C., Van Buren J.M., Akert K. Membrane morphology of the vertebrate nervous system. Prog. Brain Res. 46:1982;201-265.
36. Tetzlaff W. Tight junction contact events and temporary gap junctions in the sciatic nerve fibres of the chicken during Wallerian degeneration and subsequent regeneration. J. Neurocytol. 11:1982;839-858.
37. Miyazaki T., Takeda Y., Murakami Y., Kawano H., Shimazu T., Toya S., Uyemura K. Distribution of PASII/PMP22 and connexin 32 proteins in the peripheral nervous system. Neurochem. Int. 27:1995;377-383.
38. Nelles E., Bützler C., Jung D., Temme A., Gabriel H.-D., Dahl U., Traub O., Stümpel F., Jungermann K., Zielasek J., Toyka K.V., Dermietzel R., Willecke K. Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 93:1996;9565-9570.
39. Dermietzel R., Spray D.C. From neuro-glue ('nervenkitt') to glia: a prologue. Glia. 24:1998;1-7.
40. Majack R.A., Larsen W.J. The bicellular and reflexive membrane junctions of renomedullary interstitial cells: functional implications of reflexive gap junctions. Am. J. Anat. 157:1980;181-189.
41. Wolff J.R., Stuke K., Missler M., Tytko H., Schwarz P., Rohlmann A., Chao T.I. Autocellular coupling by gap junctions in cultured astrocytes: a new view on cellular autoregulation during process formation. Glia. 24:1998;121-140.
42. 0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell. 71:1992;565-576.
43. Balice-Gordon R.J., Bone L., Scherer S.S. Functional gap junctions in the Schwann cell myelin sheath. J. Cell Biol. 142:1998;1095-1104.
44. Pastor A., Kremer M., Möller T., Kettenmann H., Dermietzel R. Dye coupling between spinal cord oligodendrocytes: differences in coupling efficiency between gray and white matter. Glia. 24:1998;108-120.
45. Nicholson G., Corbett A. Slowing of central conduction in X-linked Charcot-Marie-Tooth neuropathy shown by brain stem auditory evoked responses. J. Neurol. Neurosurg. Psychiatry. 61:1996;43-46.
46. Bähr M., Andres F., Timmerman V., Nelis M.E., Van Broeckhoven C., Dichgans J. Central visual, acoustic, and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn205Ser mutation in the connexin 32 gene. J. Neurol. Neurosurg. Psychiatry. 66:1999;202-206.
47. Stojkovic T., Latour P., Vandenberghe A., Hurtevent J.F., Vermersch P. Sensorineural deafness in X-linked Charcot-Marie-Tooth disease with connexin 32 mutation (R142Q). Neurology. 52:1999;1010-1014.
48. Anzini P., Neuberg D.H., Schachner M., Nelles E., Willecke K., Zielasek J., Toyka K.V., Suter U., Martini R. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J. Neurosci. 17:1997;4545-4551.
49. Scherer S.S., Xu Y.-T., Nelles E., Fischbeck K., Willecke K., Bone L.J. Connexin32-null mice develop demyelinating peripheral neuropathy. Glia. 24:1998;8-20.
50. Stumpel F., Ott T., Willecke K., Jungermann K. Connexin 32 gap junctions enhance stimulation of glucose output by glucagon and noradrenaline in mouse liver. Hepatology. 28:1998;1616-1620.
51. Chanson M., Fanjul M., Bosco D., Nelles E., Suter S., Willecke K., Meda P. Enhanced secretion of amylase from exocrine pancreas of connexin32-deficient mice. J. Cell Biol. 141:1998;1267-1275.
52. Kunzelmann P., Blumcke I., Traub O., Dermietzel R., Willecke K. Coexpression of connexin45 and -32 in oligodendrocytes of rat brain. J. Neurocytol. 26:1997;17-22.
53. Dermietzel R., Farooq M., Kessler J.A., Althaus H., Hertzberg E.L., Spray D.C. Oligodendrocytes express gap junction proteins connexin32 and connexin45. Glia. 20:1997;101-114.
54. Chandross K.J. Nerve injury and inflammatory cytokines modulate gap junctions in the peripheral nervous system. Glia. 24:1998;21-31.
55. S. Zhao, D.C. Spray, Localization of Cx26, Cx32 and Cx43 in myelinating Schwann cells of mouse sciatic nerve during postnatal development, in: R. Werner (Ed.), Gap Junctions, IOS Press, Amsterdam, Netherlands, 1998, pp. 198-202.
56. Yoshimura T., Satake M., Kobayashi T. Connexin43 is another gap junction protein in the peripheral nervous system. J. Neurochem. 67:1996;1252-1258.
57. S.S. Scherer, L.J. Bone, S.M. Deschênes, K. Fischbeck, R.J. Balice Gordon, The role of gap junction protein connexin32 in the myelin sheath, in: B.H.J. Juurlink, R.M. Devon, J.R. Doucette, A.J. Nazarali, D.J. Schreyer, V.M.K. Verge (Eds.), Cell Biology and Pathology of Myelin, Plenum, New York, USA, 1997, pp. 83-102.
58. Dermietzel R., Traub O., Hwang T.K., Beyer E., Bennett M.V.L., Spray D.C., Willecke K. Differential expression of three gap junction proteins in developing and mature brain tissues. Proc. Natl. Acad. Sci. U. S. A. 86:1989;10148-10152.
59. Steinberg T.H., Civitelli R., Geist S.T., Robertson A.J., Hick E., Veenstra R.D., Wang H.Z., Warlow P.M., Westphale E.M., Laing J., Beyer E.C. Connexin43 and connexin45 form gap junctions with different molecular permeabilities in osteoblastic cells. EMBO J. 13:1994;744-750.
60. Koval M., Geist S.T., Westphale E.M., Kemendy A.E., Civitelli R., Beyer E.C., Steinberg T.H. Transfected connexin45 alters gap junction permeability in cells expressing endogenous connexin43. J. Cell Biol. 130:1995;987-995.
61. White T.W., Paul D.L., Goodenough D.A., Bruzzone R. Functional analysis of selective interactions among rodent connexins. Mol. Biol. Cell. 6:1995;459-470.
62. Veenstra R.D., Wang H.Z., Beblo D.A., Chilton M.G., Harris A.L., Beyer E.C., Brink P.R. Selectivity of connexin-specific gap junctions does not correlate with channel conductance. Circ. Res. 77:1995;1156-1165.
63. Veenstra R.D. Size and selectivity of gap junction channels formed from different connexins. J. Bioenerg. Biomembr. 28:1996;327-337.
64. Brink P.R., Cronin K., Banach K., Peterson E., Westphale E.M., Seul K.H., Ramanan S.V., Beyer E.C. Evidence for heteromeric gap junction channels formed from rat connexin43 and human connexin37. Am. J. Physiol. 273:1997;C1386-C1396.
65. Cao F., Eckert R., Elfgang C., Nitsche J.M., Snyder S.A., Hülser D.F., Willecke K., Nicholson B.J. A quantitative analysis of connexin-specific permeability differences of gap junctions expressed in HeLa transfectants and Xenopus oocytes. J. Cell Sci. 111:1998;31-43.
66. Bevans C.G., Kordel M., Rhee S.K., Harris A.L. Isoform composition of connexin channels determines selectivity among second messengers and uncharged molecules. J. Biol. Chem. 273:1998;2808-2816.
67. Gong X., Li E., Klier G., Huang Q., Wu Y., Lei H., Kumar N.M., Horwitz J., Gilula N.B. Disruption of alpha3 connexin gene leads to proteolysis and cataractogenesis in mice. Cell. 91:1997;833-843.
68. White T.W., Goodenough D.A., Paul D.L. Targeted ablation of connexin50 in mice results in microphthalmia and zonular pulverulent cataracts. J. Cell Biol. 143:1998;815-825.
69. Deschênes S.M., Walcott J.L., Wexler T.L., Scherer S.S., Fischbeck K.H. Altered trafficking of mutant connexin32. J. Neurosci. 17:1997;9077-9084.
70. Yoshimura T., Satake M., Ohnishi A., Tsutsumi Y., Fujikura Y. Mutations of connexin32 in Charcot-Marie-Tooth disease type X interfere with cell-to-cell communication but not cell proliferation and myelin-specific gene expression. J. Neurosci. Res. 51:1998;154-161.
71. Omori Y., Mesnil M., Yamasaki H. Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects. Mol. Biol. Cell. 7:1996;907-916.
72. Evans W.H., Ahmad S., Diez J., George C.H., Kendall J.M., Martin P.E. Trafficking pathways leading to the formation of gap junctions. Novartis Found. Symp. 219:1999;44-54. discussion 54-59.
73. Gow A., Lazzarini R.A. A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat. Genet. 11340:1996;422-428.
74. D'Urso D., Prior R., Greiner-Petter R., Gabreëls-Festen A.A., Müller H.W. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J. Neurosci. 18:1998;731-740.
75. Naef R., Suter U. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol. Dis. 6:1999;1-14.
76. Bruzzone R., White T.W., Scherer S.S., Fischbeck K.H., Paul D.L. Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Neuron. 13:1994;1253-1260.
77. Rabadan-Diehl C., Dahl G., Werner R. A connexin-32 mutation associated with Charcot-Marie-Tooth disease does not affect channel formation in oocytes. FEBS Lett. 351:1994;90-94.
78. Oh S., Ri Y., Bennett M.V.L., Trexler E.B., Verselis V.K., Bargiello T.A. Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease. Neuron. 19:1997;927-938.
79. Ressot C., Gomès D., Dautigny A., Pham-Dinh D., Bruzzone R. Connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease show two distinct behaviors: loss of function and altered gating properties. J. Neurosci. 18:1998;4063-4075.
80. Elfgang C., Eckert R., Lichtenberg-Fraté H., Butterweck A., Traub O., Klein R.A., Hülser D.F., Willecke K. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J. Cell Biol. 129:1995;805-817.
81. Falk M.M., Buehler L.K., Kumar N.M., Gilula N.B. Cell-free synthesis and assembly of connexins into functional gap junction membrane channels. EMBO J. 16:1997;2703-2716.
82. Paul D.L., Yu K., Bruzzone R., Gimlich R.L., Goodenough D.A. Expression of a dominant negative inhibitor of intercellular communication in the early Xenopus embryo causes delamination and extrusion of cells. Development. 121:1995;371-381.
83. Goliger J.A., Bruzzone R., White T.W., Paul D.L. Dominant inhibition of intercellular communication by two chimeric connexins. Clin. Exp. Pharmacol. Physiol. 23:1996;1062-1067.
84. Sullivan R., Huang G.Y., Meyer R.A., Wessels A., Linask K.K., Lo C.W. Heart malformations in transgenic mice exhibiting dominant negative inhibition of gap junctional communication in neural crest cells. Dev. Biol. 204:1998;224-234.
85. Bukauskas F.F., Elfgang C., Willecke K., Weingart R. Biophysical properties of gap junction channels formed by mouse connexin40 in induced pairs of transfected human HeLa cells. Pflügers Arch. 429:1995;870-872.
86. Adlkofer K., Naef R., Suter U. Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele. J. Neurosci. Res. 49:1997;671-680.
87. H.J.S. Stewart, R. Mirsky, K.R. Jessen, The Schwann cell lineage: embryonic and early postnatal development, in: K.R. Jessen, W.D. Richardson (Eds.), Glial Cell Development, BIOS Scientific Publishers, Oxford, UK, 1996, pp. 1-30.
88. Lemke G., Kuhn R., Monuki E.S., Weinmaster G. Transcriptional controls underlying Schwann cell differentiation and myelination. Ann. N. Y. Acad. Sci. 605:1990;248-253.
89. Poduslo J.F., Walikonis R.S., Domec M.C., Berg C.T., Holtz-Heppelmann C.J. The second messenger, cyclic AMP, is not sufficient for myelin gene induction in the peripheral nervous system. J. Neurochem. 65:1995;149-159.
90. Beyer E.C., Paul D.L., Goodenough D.A. Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J. Cell Biol. 105:1987;2621-2629.
91. Silander K., Meretoja P., Juvonen V., Ignatius J., Pihko H., Saarinen A., Wallden T., Herrgård E., Aula P., Savontaus M.L. Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies. Hum. Mutat. 12:1998;59-68.
92. Sahenk Z., Chen L. Abnormalities in the axonal cytoskeleton induced by a connexin32 mutation in nerve xenograft. J. Neurosci. Res. 51:1998;174-184.
93. Barrio L.C., Suchyna T., Bargiello T., Xu L.X., Roginski R.S., Bennett M.V.L., Nicholson B.J. Gap junctions formed by connexins 26 and 32 alone and in combination are differently affected by applied voltage. Proc. Natl. Acad. Sci. U. S. A. 88:1991;8410-8414.
94. C. Castro, J.M. Gomez-Hernandez, K. Silander, L.C. Barrio, Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations. J. Neurosci. (1999) 3752-3760.